Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Noriko Kinoshita and Norio Ohmagari.
Connection Strength

6.346
  1. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients. J Infect Chemother. 2021 Nov; 27(11):1669-1673.
    View in: PubMed
    Score: 0.240
  2. Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72]. Int J Infect Dis. 2021 Aug; 109:323.
    View in: PubMed
    Score: 0.238
  3. How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
    View in: PubMed
    Score: 0.238
  4. A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea. Jpn J Infect Dis. 2022 Jan 24; 75(1):36-40.
    View in: PubMed
    Score: 0.237
  5. Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result? J Infect Chemother. 2021 Aug; 27(8):1273-1275.
    View in: PubMed
    Score: 0.236
  6. Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256.
    View in: PubMed
    Score: 0.236
  7. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. J Infect Chemother. 2021 Jul; 27(7):1063-1067.
    View in: PubMed
    Score: 0.235
  8. Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486.
    View in: PubMed
    Score: 0.233
  9. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813.
    View in: PubMed
    Score: 0.231
  10. Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia. Intern Med. 2021 Mar 01; 60(5):803-805.
    View in: PubMed
    Score: 0.231
  11. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655.
    View in: PubMed
    Score: 0.231
  12. Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission. Int J Infect Dis. 2021 Mar; 104:65-72.
    View in: PubMed
    Score: 0.230
  13. Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic. Glob Health Med. 2020 Dec 31; 2(6):392-394.
    View in: PubMed
    Score: 0.230
  14. Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133.
    View in: PubMed
    Score: 0.228
  15. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098.
    View in: PubMed
    Score: 0.227
  16. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122.
    View in: PubMed
    Score: 0.225
  17. Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study. Infect Prev Pract. 2020 Sep; 2(3):100079.
    View in: PubMed
    Score: 0.224
  18. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
    View in: PubMed
    Score: 0.222
  19. A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan. Glob Health Med. 2020 Jun 30; 2(3):190-192.
    View in: PubMed
    Score: 0.222
  20. SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
    View in: PubMed
    Score: 0.222
  21. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19. Blood Purif. 2021; 50(1):129-131.
    View in: PubMed
    Score: 0.222
  22. Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020 08; 48(8):969-971.
    View in: PubMed
    Score: 0.221
  23. Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853.
    View in: PubMed
    Score: 0.220
  24. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040.
    View in: PubMed
    Score: 0.220
  25. Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040.
    View in: PubMed
    Score: 0.220
  26. SARS-CoV-2 Leakage From the Gas Outlet Port During Extracorporeal Membrane Oxygenation for COVID-19. ASAIO J. 2021 05 01; 67(5):511-516.
    View in: PubMed
    Score: 0.059
  27. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure. Front Immunol. 2021; 12:658570.
    View in: PubMed
    Score: 0.059
  28. Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep. 2021 03 10; 11(1):5563.
    View in: PubMed
    Score: 0.058
  29. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
    View in: PubMed
    Score: 0.057
  30. Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus disease 2019. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020969492.
    View in: PubMed
    Score: 0.057
  31. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
    View in: PubMed
    Score: 0.056
  32. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
    View in: PubMed
    Score: 0.056
  33. Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan. Emerg Infect Dis. 2020 Nov; 26(11):2758-2761.
    View in: PubMed
    Score: 0.056
  34. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 07 14; 117(28):16587-16595.
    View in: PubMed
    Score: 0.056
  35. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Viruses. 2020 06 10; 12(6).
    View in: PubMed
    Score: 0.055
  36. SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.